Open Label
Open-label studies play a critical role in clinical development by allowing both investigators and participants to know which treatment is being administered. These studies provide valuable long-term safety, tolerability, and effectiveness data while supporting patient retention and real-world treatment evaluation across diverse therapeutic areas.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Advancing Clinical Research Through Open-Label Studies
Open-label studies provide essential insights into treatment safety, patient adherence, and long-term outcomes beyond controlled trial settings. These studies often serve as extension trials following randomized controlled studies and help sponsors better understand how therapies perform in real-world clinical environments.
Our experienced research teams support efficient study execution, participant engagement, and comprehensive data collection throughout the study lifecycle.
Conditions Covered
Therapeutic Areas Supported Through Open-Label Research
Our sites have experience supporting open-label studies across a broad range of indications, including:
Psychiatry
CNS Disorders
Behavioral Health
Pain Management
Metabolic Disorders
Neurology
Rare Diseases
Women's Health
Gastroenterology
Inflammatory Conditions
Our Approach
Why Sponsors Choose CenExel for Open Label Studies
Our open-label capabilities go beyond recruitment — providing scientific rigor, efficient study execution, and high-quality data to advance clinical research with confidence.
01
Strong Patient Retention
Dedicated engagement strategies help maintain participant involvement throughout long-term studies.
02
Long-Term Safety Monitoring
Comprehensive safety assessments and follow-up procedures support reliable data collection.
03
Experienced Research Teams
Investigators and coordinators are experienced in managing open-label and extension studies across multiple therapeutic areas.
04
High-Quality Data Collection
Standardized processes ensure consistent and accurate reporting of clinical outcomes.
Phase Coverage
Supported Trial Phases
We support open-label studies across multiple stages of clinical development, including extension and post-marketing research programs.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our operational infrastructure enables efficient study startup, participant retention, safety oversight, and regulatory compliance across all study phases.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.